Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Vaccine|April 21, 2016
Immunity to hepatitis B persists in adolescents 15-16 years of age vaccinated in infancy with three doses of hepatitis B vaccineOlivier Van Der Meeren, Ulrich Behre, Priya Crasta
Human Vaccines & Immunotherapeutics|November 11, 2020
Safety, reactogenicity, and immunogenicity of a 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine in healthy toddlers: results from a phase I, randomized trialMichael Horn, Ulrich Behre, Magali Traskine, et al.
Human Vaccines & Immunotherapeutics|September 23, 2016
Lasting immune memory against hepatitis B in 12-13-year-old adolescents previously vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancyUlrich Behre, Olivier Van Der Meeren, Priya Crasta, et al.
Frontiers in Pediatrics|March 3, 2023
Safety of Pelargonium extract EPs 7630 in young children with acute bronchitisWolfgang Kamin, Ulrich Behre, Klaus Helm, et al.
Human Vaccines & Immunotherapeutics|April 18, 2012
Long-term anti-HBs antibody persistence and immune memory in children and adolescents who received routine childhood hepatitis B vaccinationUlrich Behre, Gerhard Bleckmann, Priya Diana Crasta, et al.
Human Vaccines & Immunotherapeutics|August 18, 2018
Long-term antibody persistence against hepatitis B in adolescents 14-15-years of age vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancyTino F Schwarz, Ulrich Behre, Thomas Adelt, et al.
The Pediatric Infectious Disease Journal|January 25, 2005
Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate VaccineIrmingard Tichmann-Schumann, Peter Soemantri, Ulrich Behre, et al.
European Journal of Pediatrics|June 2, 2007
Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 monthsFred Zepp, Ulrich Behre, Klaus Kindler, et al.
European Journal of Pediatrics|January 20, 2007
Booster vaccination and 1-year follow-up of 4-8-year-old children with a reduced-antigen-content dTpa-IPV vaccineRoland Sänger, Ulrich Behre, Karl-Heinz Krause, et al.
Human Vaccines & Immunotherapeutics|July 16, 2015
Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized studyBarbara Romanowski, Tino F Schwarz, Linda Ferguson, et al.
Pageof 2